Moneycontrol PRO
HomeNewsAurobindopharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Ashok Leyland, HDFC Bank among 10 portfolio picks by Emkay Global

    Here is a list of top 10 stocks handpicked by Emkay Global that could return 13-85 percent over the next 12-18 months

  • Sell Aurobindo Pharma, target Rs 485: Vinay Rajani

    Sell Aurobindo Pharma, target Rs 485: Vinay Rajani

    We recommend selling Aurobindo Pharma for the downside target of Rs 485 with a stop loss placed at Rs 570.

  • 2008 vs 2018: Why investors should be worried this time around

    2008 vs 2018: Why investors should be worried this time around

    The Nifty is trading above its 50, 100 and 200- daily moving average (DMA), indicating a bullish trend for the short to medium term.

  • Buy or sell: Top stock trading ideas by market experts which are good short term bets

    Buy or sell: Top stock trading ideas by market experts which are good short term bets

    Vinay Rajani of HDFC Securities is of the view that one can sell Aurobindo Pharma with target at Rs 485 and stop loss at Rs 570, a sell in Muthoot Finance with target at Rs 350 and stop loss at Rs 395 and a buy in Cholamandalam Investment with target at Rs 1,700 and sto loss at Rs 1,490.

  • Crude oil, rupee, earnings to dictate market trend; these 10 stocks can give 28-94% returns

    Crude oil, rupee, earnings to dictate market trend; these 10 stocks can give 28-94% returns

    Higher crude oil prices and the rupee’s weakness will continue to dampen sentiment putting pressure on the fiscal deficit and bond yields in the short term, Vikas Jain of Reliance Securities feels

  • Top 10 stocks from BSE 100 index with highest buy rating

    Top 10 stocks from BSE 100 index with highest buy rating

    On a year-to-date (YTD) basis, as many as six out of 10 stocks failed to even match the Sensex’s return of 1.09 percent.

  • Buy Aurobindo Pharma, target Rs 792: SMC Global Securities

    Buy Aurobindo Pharma, target Rs 792: SMC Global Securities

    "The stock will see a target price of Rs 792 in 8-10 months timeframe on a one-year average P/E of 16.77x and FY19 (E) earnings of Rs 47.20," says a report by SMC Global Securities.

  • Top 20 stocks that can deliver up to 50% returns; do you own any?

    Top 20 stocks that can deliver up to 50% returns; do you own any?

    Here is the list of 20 stocks that could give up to 50 percent return over a period of one year.

  • Buy Aurobindo Pharma, target Rs 680: Achin Goel

    Buy Aurobindo Pharma, target Rs 680: Achin Goel

    "Traders can accumulate the stock in the range of Rs 612-618 for the target of Rs 680 and a stop loss below Rs 587," says Achin Goel, Head of Wealth Management and Financial Planning at Bonanza Portfolio Ltd.

  • Buy quality stocks on declines in Nifty; 5 stocks which could give up to 16% return

    Buy quality stocks on declines in Nifty; 5 stocks which could give up to 16% return

    "Increased interest in 10,200 Put suggests a positive shift in the Nifty range. However, a proximity to resistance levels may induce some small correction which we think would provide a buying opportunity in the near term," says Achin Goel, Head of Wealth Management and Financial Planning, Bonanza Portfolio Ltd.

  • Top 10 stocks handpicked by experts to buy in FY19 which can give up to 40% return

    Top 10 stocks handpicked by experts to buy in FY19 which can give up to 40% return

    FY19 promises to be a volatile year for equity markets with indices moving 10-20% in either direction. There are plenty of global headwinds which might arrest the liquidity flow while on the other hand uncertainty around general elections, rising crude oil prices, as well as state election, rate action by the central bank is likely to cap upside.

  • Nifty to remain soft in near term; these 24 picks can give up to 168% return

    Nifty to remain soft in near term; these 24 picks can give up to 168% return

    Prabhudas Lilladher expects the Nifty to trade in a range of 9,640-10,500 in the near term.

  • Short Bharti Airtel, Godfrey Phillips, HPCL; buy IGL, Sun TV Network: Sudarshan Sukhani

    Short Bharti Airtel, Godfrey Phillips, HPCL; buy IGL, Sun TV Network: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can short Bharti Airtel, Godfrey Phillips and HPCL and can buy Indraprastha Gas and Sun TV Network.

  • Top 10 money making ideas by experts in a falling market which could give up to 14% return

    Top 10 money making ideas by experts in a falling market which could give up to 14% return

    Most analysts agree to one thing that it is a sell on rise kind of market as Nifty witnesses supply pressure whenever it comes closer to 10,600 levels.

  • Buy, Sell, Hold: Analysts are tracking 4 stocks and 2 sectors on March 5

    Buy, Sell, Hold: Analysts are tracking 4 stocks and 2 sectors on March 5

    Credit Suisse has upgraded Aurobindo to Outperform from Neutral rating with a target price at Rs 750 per share as the stock is attractive for low valuations at 13x FY19 EPS.

  • Market drifts lower dragged by metals; 4 stocks to buy or sell today for good returns

    Market drifts lower dragged by metals; 4 stocks to buy or sell today for good returns

    The Nifty metal Index was down over 2 percent after dragged by stocks like NALCO, JSW Steel, Jindal Steel & Power, Vedanta, Hindalco Industries, NMDC and Coal India.

  • Bull's Eye: Buy Aurobindo Pharma, Syndicate Bank, Godrej Agrovet; sell Adani Enterprises, SAIL

    Bull's Eye: Buy Aurobindo Pharma, Syndicate Bank, Godrej Agrovet; sell Adani Enterprises, SAIL

    Sameet Chavan of Angel Broking suggests buying MCX India with a target of Rs 855.

  • Buy Sun TV, Havells India, Aurobindo Pharma, Mahanagar Gas: Rajat Bose

    Buy Sun TV, Havells India, Aurobindo Pharma, Mahanagar Gas: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying Sun TV, Havells India, Aurobindo Pharma and Mahanagar Gas.

  • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for February 27

    Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for February 27

    Mitessh Thakkar of miteshthacker.com recommends buying Bharat Electronics with a stop loss of Rs 151.50 for target of Rs 164, Can Fin Homes with a stop loss of Rs 528 for target of Rs 560 and Godrej Consumer Products with a stop loss of Rs 1063 and target of Rs 1095.

  • Buy Ipca Labs, Aurobindo Pharma; sell Siemens, Bosch: Mitessh Thakkar

    Buy Ipca Labs, Aurobindo Pharma; sell Siemens, Bosch: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com is of the view that one can buy Ipca Labs and Aurobindo Pharma and can sell Siemens and Bosch.

  • Buy RIL, Hindalco, Syndicate Bank, BOI, Aurobindo Pharma: Ashwani Gujral

    Buy RIL, Hindalco, Syndicate Bank, BOI, Aurobindo Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com advises buying RIL, Hindalco, Syndicate Bank, BOI and Aurobindo Pharma.

  • Sell Canara Bank, NMDC, Godfrey Phillips: Sudarshan Sukhani

    Sell Canara Bank, NMDC, Godfrey Phillips: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com advises selling Canara Bank, NMDC and Godfrey Phillips.

  • Buy Ashok Leyland, NMDC, JSW Steel: Ashwani Gujral

    Buy Ashok Leyland, NMDC, JSW Steel: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ashok Leyland, NMDC and JSW Steel.

  • Mid & smallcap stocks look expensive! 10 largecap which could give 40% return

    Mid & smallcap stocks look expensive! 10 largecap which could give 40% return

    The liquidity drive which pushed benchmark indices to record highs also pushed many stocks especially in the small and midcap space to valuations beyond their historic averages.

  • Sell Aurobindo Pharma, Coal India; Buy Gati: Ashwani Gujral

    Sell Aurobindo Pharma, Coal India; Buy Gati: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may sell Aurobindo Pharma and Coal India.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347